Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px
Document › Details

Sygnis AG. (4/22/15). "Press Release: Sygnis Appoints Dr. Miguel-Antonio Viribay as Vice President Sales and Marketing". Madrid & Heidelberg.

Organisations Organisation Sygnis AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard)
  Group Genetrix (ES) (Group)
  Organisation 2 Thermo Fisher (Group)
Products Product SunScript™ Reverse Transcriptase (product series)
  Product 2 TruePrime™ kit (product series)
Persons Person Viribay, Miguel-Antonio (Sygnis 201504– VP Sales + Marketing before Thermo Fisher + Agilent + Life Technologies)
  Person 2 de la Huerta Martinez, Pilar (Sygnis Pharma 201303– CEO + CFO before Genetrix CEO before Zeltia)

> Dr. Viribay adds more than 16 years of international experience in molecular biology and biotechnology markets

> Strong focus on boosting international sales, mainly in Europe and the US

SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that Dr. Miguel-Antonio Viribay has joined SYGNIS and will assume responsibility for the further development, implementation and execution of sales and marketing strategies as Vice President Sales and Marketing.

Dr. Viribay has over 16 years of successful international experience in the biotech industry. He held executive positions in the sales and marketing departments of leading American companies operating in Southern Europe, such as Life Technologies, Agilent or, more recently, Thermo Fisher. All these companies specialize in products for molecular biology and next generation sequencing, priority areas also for SYGNIS. Mr. Viribay holds a PhD in Molecular Genetics.

In his newly created position as Vice President Sales and Marketing, Dr. Viribay will be responsible for deepening the marketing approach, based on direct sale of SYGNIS products as well as on agreements with SYGNIS’ distribution partners worldwide, developing new business and sales strategies, and promoting online sales in order to boost international sales, especially in the European and US markets.

“We are very much looking forward to welcoming Dr. Viribay to SYGNIS”, Pilar de la Huerta, CEO and CFO of SYGNIS commented. “Dr. Viribay’s extensive experience in world-wide marketing and sales in the biotechnology industry combined with his scientific excellence in molecular science will support and further enhance SYGNIS position as a leading provider of innovative products and technologies for DNA amplification and sequencing in growth markets, especially in Europe and the US. Now that we have expanded our scope of business and are selling our own products, Dr. Viribay will play a key role as we continue to pursue our growth strategy and position our products for long- term success.”

“I am very pleased to join SYGNIS at this exciting point in its journey,” Dr. Miguel-Antonio Viribay added. “With the launch of its second product line in just seven months the company paved the ground for future success and I am very much looking forward to contribute to its next phase of growth and joining this proven and dynamic management team.”

For further information please contact:

Pilar de la Huerta
Phone: +34 91 192 36 50

MC Services AG
Raimund Gabriel
Managing Partner
Phone: +49 89 210228 30

Record changed: 2017-04-02


Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Genetrix (ES) (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

» top